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Letters to the Editor 
Dear Editor 
Kikuchi’s disease and systemic lupus 
erythematosus 
We read with interest the case report by Abba 
et al. (1) on Kikuchi’s disease presenting as 
bilateral hilar lymphadenopathy. We feel the 
report fails to stress the importance of the associ- 
ation between histiocytic necrotizing lymphad- 
enitis (HNL) and connective tissue diseases, in 
particular systemic lupus erythematosus (SLE). 
We recently investigated a 29-year-old female 
with fever, cervical lymphadenopathy and a pru- 
ritic maculo-papular rash on the trunk and arms. 
The clinical picture was typical of other reports 
of Kikuchi’s disease (2). Lymph node biopsy 
showed the ‘pathognomic’ features of Kikuchi’s 
disease. The histological appearances were 
confirmed by independent review. 
Over the following months, she developed a 
more florid rash with inflammatory plaques of 
discoid lupus, confirmed on skin biopsy. Her 
vision deteriorated in the left eye with retinal 
abnormalities consistent with SLE. Autoanti- 
body screening confirmed the diagnosis of SLE 
with positive ANA and antibodies to double- 
stranded DNA. She has been treated by pred- 
nisolone and hydroxychloroquine, and is 
currently in remission. 
The pathological feature of HNL in associ- 
ation with SLE has been reported in a small 
number of patients, and the SLE may be 
extremely florid in its activity (3,4). Our patients 
with SLE still required significant immuno- 
suppressant treatment to suppress disease 
activity. 
Like many reports on Kikuchi’s disease, the 
report by Abba et al. continues to reinforce 
HNL as a brief benign self-limiting condition, 
and only mentions in passing the association 
with other systemic conditions. They have not 
excluded SLE or overlap syndrome in their 
patient, on the basis of the investigations 
reported. 
It is essential that clinicians and pathologists 
appreciate that some patients with a pathologi- 
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cal diagnosis of HNL may have severe, poten- 
tially life-threatening disorders. It may be best to 
avoid the term ‘Kikuchi’s disease’, and simply 
describe the pathological feature of histiocytic 
necrotizing lymphadenitis. 
C. W. H. DAVIES AND C. G. WATHEN 
Department of Thovacic Medicine 
Wycombe General Hospital 
High Wycombe, U.K. 
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Reply to Drs Davies and Wathen 
We appreciate the comments made by Drs 
Davies and Wathen on our report and agree with 
them fully that some patients presenting with 
Kikuchi’s disease may indeed have potentially 
life-threatening disorders. This underlines the 
need for close follow-up of all patients with the 
histological diagnosis of histiocytic necrotizing 
lymphadenitis (HNL). As mentioned in our 
report, HNL and SLE share certain histopatho- 
logical characteristics and indeed not less than 
13 cases have been reported in the literature 
associating HNL and SLE (1). We have 
followed-up nine patients (of a group of 13 seen 
in our hospital) with histological diagnosis of 
HNL for at least 18 months. In all patients, 
lymphadenopathy and other symptoms subsided 
and no other features of connective tissue disease 
manifested. One of our patients with mixed 
connective tissue disease (MCTD) developed 
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lymphadenopathy with histological feature of 
HNL. The development of HNL did not affect 
the course of her MCTD. The aim of our report 
was to highlight the peculiarity of presentation 
of this condition as bilateral hilar lymphaden- 
opathy, which would be of immense interest to 
pulmonologists and pulmonary pathologists. 
Unlike their patient, ours had none of the 
American Rheumatism Association clinical cri- 
teria for the diagnosis of SLE (2), hence our 
failure to pursue laboratory criteria. We have 
followed this patient now for nearly 4 years. He 
remains well and asymptomatic. 
The variable presentation and progression and 
the association with various physical, chemical, 
autoimmune and infective conditions indicates 
that this condition is a consequence of one or 
more (variable) stimuli. Until a unitary expla- 
nation is identified, it is best to treat each patient 
on merit. 
A. A. ABBA 
Department of Medicine 
King Saudi University 
Riyadh, Saudi Arabia 
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Dear Editor 
Chylothorax in liver cirrhosis 
We have read with great interest the article by 
Valdks et al. (1) in which two cases of chylo- 
thorax caused by liver cirrhosis were reported. 
The authors emphasize the rarity of chylothorax 
secondary to hepatic cirrhosis, which makes up 
approximately 1% of all chylothorax patients. 
We wish to report another patient with right 
cylothorax due to liver cirrhosis. 
A 76-year-old woman was hospitalized in June 
1988 because of dyspnoea of several days dur- 
ation. Postnecrotic hepatic cirrhosis had been 
diagnosed 19 years before. In that time, portal 
hypertension was present. A splenorenal shunt 
and splenectomy were performed. Six months 
before admission, ascites developed. Paracen- 
tesis resulted in the removal of 3500 ml of milky 
liquid. Biochemical investigation of the perito- 
neal fluid was as follows: total protein 3.2 g 
dl- ‘, lactate dehydrogenase (LDH) 87 IU 1 - I, 
glucose 115 mg dl-l, cholesterol 34 mg dl - ‘, 
triglycerides 193 mg dl - ‘, amylase 173 U 1 - ‘, 
lysozyme 21.2 mg dl- ‘, a,-antitrypsin 125 mg 
dl - I, carcino-embryonic antigen (CEA) 0.33 ng 
ml-‘, pH 7.40, PCO, 43.5 mmHg, PO, 
73 mmHg, [HC03-] 27.5 mEq l- ‘, leucocytes 
1100 mmp3. Gram stain, acid-fast stain, culture 
and cytologic findings for malignancy were nega- 
tive. On admission, clinical examination showed 
chronic hepatopathic stigmata, hepatomegaly, 
ascites and a right-sided pleural effusion con- 
firmed by chest radiograph. Blood pressure was 
120/70 mmHg, and heart rate was 84 beats 
min- ‘. Blood analysis results were as follows: 
haemoglobin 12.8 g dl - ‘, haematocrit 38%, 
leucocytes 7500 mm - 3, differential leucocyte 
counts normal, platelet count 256 000 mm - 3, 
prothrombin activity 53%, partial thromboplas- 
tin time 30.5 s, total protein 7.36 g dl- ‘, total 
bilirubin O-8 1 mg dl - ‘, triglycerides 34 mg dl ~ ‘, 
cholesterol 123 mg dl - ‘, creatinine 2.24 mg 
dl - ‘, blood ammonia 134 mg dl - ‘, immuno- 
globulin G 3430 mg dl- ‘, other biochemical 
parameters normal. Abdominal ultrasonography 
showed hepatomegaly without focal lesions and 
ascites. Thirteen thoracenteses, performed in a 
period of 3 months, resulted in the removal of 
29 500 ml of milky liquid. Characteristics of the 
pleural fluid were as follows: protein 2.3 g dl - ‘, 
pleural fluid: serum protein ratio 0.3, LDH 171 
IU l- ‘, pleural fluid: serum LDH ratio 0.4, 
glucose 90 mg dl - ‘, cholesterol 46 mg dl - ‘, 
triglycerides 121 mg dl - ‘, pleural fluid: serum 
triglycerides ratio 2.2, amylase 195 U 1~ ‘, 
lysozyme 22.2 mg dl - ‘, a,-antitrypsin 118 mg 
dl-l, CEA 1.3 ng ml ~ ‘, pH 7.48, PCO, 
45 mmHg, PO, 48.3 mmHg, [HC03-] 29.8 mEq 
1 - ‘, leucocytes 1200 mm - 3 of which 60% lym- 
phocytes, chylomicrons present. Gram stain, 
acid-fast stain, culture and cytologic findings for 
malignancy were negative. Total parenteral 
nutrition was started without reduction of 
